These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9893028)

  • 1. Antigen presentation by cisplatin-activated macrophages: role of soluble factor(s) and second messengers.
    Singh RA; Sodhi A
    Immunol Cell Biol; 1998 Dec; 76(6):513-9. PubMed ID: 9893028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and activation of lyn in macrophages treated in vitro with cisplatin: regulation by kinases, phosphatases and Ca2+/calmodulin.
    Singh RA; Sodhi A
    Biochim Biophys Acta; 1998 Oct; 1405(1-3):171-9. PubMed ID: 9784629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin-treated macrophages produce oncostatin M: regulation by serine/threonine and protein tyrosine kinases/phosphatases and Ca2+/calmodulin.
    Singh RA; Sodhi A
    Immunol Lett; 1998 Jul; 62(3):159-64. PubMed ID: 9698114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and activation of RAS and mitogen-activated protein kinases in macrophages treated in vitro with cisplatin: regulation by kinases, phosphatases and Ca2+/calmodulin.
    Singh RA; Sodhi A
    Immunol Cell Biol; 1999 Aug; 77(4):356-63. PubMed ID: 10457204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LFA-1-dependent tumoricidal activity of cisplatin-treated macrophages.
    Singh RA; Sodhi A
    Immunol Cell Biol; 1998 Aug; 76(4):343-9. PubMed ID: 9723775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of calcium and calmodulin in the activation of murine peritoneal macrophages with cisplatin.
    Sodhi A; Kumar R
    Int J Immunopharmacol; 1994 Dec; 16(12):1003-10. PubMed ID: 7705961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of NF-kappa B translocation in macrophages treated in vitro with cisplatin.
    Sodhi A; Singh RA
    Immunol Lett; 1998 Aug; 63(1):9-17. PubMed ID: 9719433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of nitric oxide production by murine peritoneal macrophages treated in vitro with chemokine monocyte chemoattractant protein 1.
    Biswas SK; Sodhi A; Paul S
    Nitric Oxide; 2001 Dec; 5(6):566-79. PubMed ID: 11730364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin stimulates protein tyrosine phosphorylation in macrophages.
    Kumar R; Shrivastava A; Sodhi A
    Biochem Mol Biol Int; 1995 Mar; 35(3):541-7. PubMed ID: 7539662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin primes murine peritoneal macrophages for enhanced expression of nitric oxide, proinflammatory cytokines, TLRs, transcription factors and activation of MAP kinases upon co-incubation with L929 cells.
    Chauhan P; Sodhi A; Shrivastava A
    Immunobiology; 2009; 214(3):197-209. PubMed ID: 19215802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of Ras and MAP kinase (ERK-1) in cisplatin-induced activation of murine bone marrow-derived macrophages.
    Shishodia S; Sodhi A; Shrivastava A
    Biochem Mol Biol Int; 1998 Jul; 45(3):527-34. PubMed ID: 9679653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced immune system activation after treatment with novel antineoplastic platinum agents.
    Muenchen HJ; Aggarwal SK
    Anticancer Res; 1998; 18(4A):2631-6. PubMed ID: 9703920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on pinocytosis and antigen presentation by murine peritoneal macrophages to T cells in vitro after cisplatin treatment.
    Sodhi A; Gupta P
    Arch Immunol Ther Exp (Warsz); 1988; 36(3):315-23. PubMed ID: 3250354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular mechanisms responsible for exercise-induced suppression of macrophage antigen presentation.
    Ceddia MA; Voss EW; Woods JA
    J Appl Physiol (1985); 2000 Feb; 88(2):804-10. PubMed ID: 10658054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of Toll-like receptors in murine peritoneal macrophages in vitro on treatment with cisplatin.
    Tarang S; Sodhi A; Chauhan P
    Int Immunol; 2007 May; 19(5):635-43. PubMed ID: 17446211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between cisplatin treated murine peritoneal macrophages and L929 cells: involvement of adhesion molecules, cytoskeletons, upregulation of Ca2+ and nitric oxide dependent cytotoxicity.
    Sodhi A; Chauhan P
    Mol Immunol; 2007 Mar; 44(9):2265-76. PubMed ID: 17188358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Dalton's lymphoma on the antigen presentation of murine peritoneal macrophages.
    Kumar A; Singh SM
    Cancer Lett; 1995 Jun; 92(2):151-7. PubMed ID: 7600525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of murine peritoneal macrophages after cisplatin and taxol combination.
    Muenchen HJ; Aggarwal SK
    Anticancer Drugs; 1997 Sep; 8(8):784-9. PubMed ID: 9396623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin-treated murine peritoneal macrophages induce apoptosis in L929 cells: role of Fas-Fas ligand and tumor necrosis factor-tumor necrosis factor receptor 1.
    Chauhan P; Sodhi A; Tarang S
    Anticancer Drugs; 2007 Feb; 18(2):187-96. PubMed ID: 17159605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monocyte chemoattractant protein-1-induced activation of p42/44 MAPK and c-Jun in murine peritoneal macrophages: a potential pathway for macrophage activation.
    Sodhi A; Biswas SK
    J Interferon Cytokine Res; 2002 May; 22(5):517-26. PubMed ID: 12060490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.